Kwan Chiu-Yin, Zhang Wen-Bo, Kwan Tony K, Sakai Yasushi
Department of Medicine, Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada.
Naunyn Schmiedebergs Arch Pharmacol. 2003 Jul;368(1):1-9. doi: 10.1007/s00210-003-0759-7. Epub 2003 Jun 11.
Cumulative addition of atropine to the organ bath containing endothelium-intact (+E) rat aorta, which was precontracted with phenylephrine (PE, 1 microM) and subsequently relaxed with carbachol (1 microM), caused biphasic changes in the vascular contractility of +E rat aortic rings. Low concentrations of atropine (10 nM-1.0 microM) caused progressive restoration of contraction to PE; whereas at higher concentrations (1-100 microM), atropine caused progressive relaxation. Atropine-induced aortic relaxation was significantly inhibited upon endothelium removal by either rubbing or saponin treatment, but considerable relaxation still persisted in the range of 30-100 microM atropine. Similar findings were also obtained when the nitric oxide (NO) generation was inhibited with 300 microM NO synthase inhibitor, L-NAME. Atropine-induced relaxation was also observed when 5-hydroxytryptamine (5-HT) was used as the agonist and the atropine-relaxation was more potent at lower concentrations of PE and 5-HT. However, atropine had no effect on the contraction elicited by KCl or prostaglandin F(2 alpha). Also, atropine-induced relaxation was not affected by indomethacin (1-10 microM), nicotine (10-100 microM) or hexamethonium (30 microM). Pretreatment of +E aorta with tetraethylammonia (TEA, 3-10 mM) or 4-aminopyridine (4-AP, 1-3 mM) showed prominent inhibitory effect on atropine-induced relaxation; on the other hand, preincubation with glibenclamide (1-10 microM), BaCl(2) (1-30 microM) or 2 microM charybdotoxin and apamin, had little effect on the relaxation induced by atropine. When added to tissues after relaxation to atropine, TEA and 4-AP concentration-dependently reversed the relaxation in -E aorta, whereas in +E aorta, TEA up to 30 mM and 4-AP up to 10 mM only partially affected atropine-induced relaxation. Although TEA and 4-AP potentiated the PE-contraction, such potentiation is unlikely to contribute to the change in sensitivity to atropine-induced relaxation, since in the presence of 15 mM KCl, which also potentiated PE-contraction to a comparable extent, the atropine-relaxation remains unchanged. Scopolamine also acts like atropine, except that the effect of scopolamine was smaller than that of atropine and is primarily endothelium-dependent. Atropine-induced relaxation also occurs in medium artery (renal artery) and small muscular artery (mesenteric artery). In conclusion, atropine-relaxation is mediated in part via voltage-dependent K(+) channels in both smooth muscle and endothelium and forms the mechanistic basis for the observed vasodilation, reduced blood pressure and facial flushing following atropine overdose.
在含有完整内皮(+E)的大鼠主动脉的器官浴槽中,预先用去氧肾上腺素(PE,1微摩尔)预收缩,随后用卡巴胆碱(1微摩尔)舒张,然后向其中累积添加阿托品,导致+E大鼠主动脉环的血管收缩性发生双相变化。低浓度的阿托品(10纳摩尔 - 1.0微摩尔)使对PE的收缩逐渐恢复;而在较高浓度(1 - 100微摩尔)时,阿托品导致逐渐舒张。通过摩擦或皂角苷处理去除内皮后,阿托品诱导的主动脉舒张受到显著抑制,但在30 - 100微摩尔阿托品范围内仍有相当程度的舒张。当用300微摩尔一氧化氮合酶抑制剂L - 硝基精氨酸甲酯(L - NAME)抑制一氧化氮(NO)生成时,也得到了类似的结果。当使用5 - 羟色胺(5 - HT)作为激动剂时,也观察到了阿托品诱导的舒张,并且在较低浓度的PE和5 - HT时,阿托品舒张作用更强。然而,阿托品对氯化钾或前列腺素F2α引起的收缩没有影响。此外,阿托品诱导的舒张不受吲哚美辛(1 - 10微摩尔)、尼古丁(10 - 100微摩尔)或六甲铵(30微摩尔)的影响。用四乙铵(TEA,3 - 10毫摩尔)或4 - 氨基吡啶(4 - AP,1 - 3毫摩尔)预处理+E主动脉对阿托品诱导的舒张显示出显著的抑制作用;另一方面,用格列本脲(1 - 10微摩尔)、氯化钡(1 - 30微摩尔)或2微摩尔蝎毒素和蜂毒明肽预孵育,对阿托品诱导的舒张影响很小。当在对阿托品舒张后添加到组织中时,TEA和4 - AP浓度依赖性地逆转了 - E主动脉中的舒张,而在+E主动脉中,高达30毫摩尔的TEA和高达10毫摩尔的4 - AP仅部分影响阿托品诱导的舒张。尽管TEA和4 - AP增强了PE收缩,但这种增强不太可能导致对阿托品诱导舒张的敏感性变化,因为在存在15毫摩尔氯化钾的情况下,氯化钾也将PE收缩增强到相当程度,而阿托品舒张保持不变。东莨菪碱的作用与阿托品相似,只是东莨菪碱的作用比阿托品小,且主要依赖于内皮。阿托品诱导的舒张也发生在中动脉(肾动脉)和小肌性动脉(肠系膜动脉)中。总之,阿托品舒张部分是通过平滑肌和内皮中的电压依赖性钾通道介导的,这为阿托品过量后观察到的血管舒张、血压降低和面部潮红形成了机制基础。